The dysplastic nevus

Current Problems in Dermatology

Volumn 15, Issue 5, 2003, Pages 170-175

  Rozycki, Jane L ^a   Barrett, Terry L ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL EXAMINATION; DYSPLASTIC NEVUS; EXCISION; HISTOPATHOLOGY; HUMAN; NOMENCLATURE; SKIN BIOPSY; TUMOR CLASSIFICATION;

EID: 0141848444     PISSN: 10400486     EISSN: None     Source Type: Journal    
DOI: 10.1067/S1040-0486(03)00029-2     Document Type: Article

References (41)

1. Kanzler MH, Mraz-Gernhard S. Primary cutaneous malignant melanoma and its precursor lesions: diagnostic and therapeutic overview. J Am Acad Dermatol 2001;45:260-76.
2. Greene MH, Clark WL, Tucker MA, Elder DE, Kraemer KH, Fraser MC, et al. Precursor naevi in cutaneous malignant melanoma: a proposed nomenclature [letter]. Lancet 1980;2(8202):1024.
3. Haley JC, Hood AF, Tsu-Yi-Chuang, Rasmussen J. The frequency of histologically dysplastic nevi in 199 pediatric patients. Pediatr Dermatol 2000;17:266-9.
4. Augustsson A, Stierner U, Rosdahl I, Suurkula M. Common and dysplastic naevi as risk factors for cutaneous malignant melanoma in a Swedish population. Acta Derm Venereal 1991;71:518-24.
5. Clark WH, Reimer RR, Greene MH, Ainsworth AM, Mastrangelo MJ. Origin of familial malignant melanomas from heritable melanocytic lesions. Arch Dermatol 1978;114:732-8.
6. NIH Consensus Conference. Diagnosis and treatment of early melanoma. JAMA 1992;268:1314-9.
7. Elenitsas R, Halpern AC. Eczematous halo reaction in atypical nevi. J Am Acad Dermatol 1996;34:357-61.
8. Murphy GF, Mihm MC. Recognition and evaluation of cytological dysplasia in acquired melanocytic nevi. Human Pathol 1999;33:506-12.
9. Khare VK, Albino AP, Reed JA. The neuropeptide/mast cell secretagogue substance P is expressed in cutaneous melanocytic lesions. J Cutan Pathol 1998;25:2-10.
10. Rhodes AR, Mihm MC, Weinstock MA. Dysplastic melanocytic nevi: a reproducible histologic definition emphasizing cellular morphology. Mod Pathol 1989;2:306-19.
11. Pozo L, Naase M, Cerio R, Blanes A, Diaz-Cano SJ. Critical analysis of histologic criteria for grading atypical (dysplastic) melanocytic nevi. Am J Clin Pathol 2001;115:194-204.
12. Jones RE. Clark's nevus versus dysplastic nevus [letter]. Am J Dermatopathol 1995;17:104.
13. Greene MH. The genetics of hereditary melanoma and nevi. Cancer 1999;86:2464-77.
14. Hruban RH, Peterson GM, Goggins M, Tersmette AC, Offerhaus GJA, Falatko F, et al. Familial pancreatic cancer. Ann Oncol 1999;4:4-8.
15. Goldstein AM, Fraser MC, Struewing JP, Hussussian CJ, Ranade K, Zametkin DP, et al. Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations. N Engl J Med 1995;333:970-4.
16. Kelly JW, Yeatman JM, Regalia C, Mason G, Henham AP. A high incidence of melanoma found in patients with multiple dysplastic nevi by photographic surveillance. Med J Aust 1997;167:191-4.
17. Williams ML, Sagebiel RW. Melanoma risk factors and atypical moles. West J Med 1994;160:343-50.
18. Bataille V, Bishop JA, Sasieni P, Swerdlow AJ, Pinney E, Griffiths K, et al. Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study. Br J Cancer 1996;73:1605-11.
19. Rigel DS, Rivers JK, Kopf AW, Friedman RJ, Vinokur AF, Heilman ER, et al. Dysplastic nevi. Markers for increased risk for melanoma. Cancer 1989;63:386-9.
20. Augustsson A. Melanocytic naevi, melanoma and sun exposure. Acta Derm Venereol Suppl (Stockh) 1991;166:1-34.
21. Holly EA, Kelly JW, Shpall SN, Chiu SH. Number of melanocytic nevi as a major risk factor for malignant melanoma. J Am Acad Dermatol 1987;17:459-68.
22. Elder DE, Greene MH, Guerry DP, Kraemer KH, Clark WH. The dysplastic nevus syndrome; our definition. Am J Dermatopathol 1982;4:455-9.
23. Roush GC, Barnhill RL, Duray PH, Titus LJ, Ernstoff MS, Kirkwood JM. Diagnosis of the dysplastic nevus in different populations. J Am Acad Dermatol 1986;14:419-25.
24. Lee AS, Rhodes AR, Sober AJ. Dysplastic melanocytic nevi and cutaneous melanoma: markers of increased melanoma risk for affected persons and blood relatives. J Am Acad Dermatol 1990;22:69-75.
25. Cook MG, Fallowfield ME. Dysplastic naevi: an alternative view. Histopathology 1990;16:29-35.
26. Annessi G, Cattaruzza MS, Abeni D, Baliva G, Laurenza M, Macchini V, et al. Correlation between clinical atypia and histologic dysplasia in acquired melanocytic nevi. J Am Acad Dermatol 2001;45:77-85.
27. Klein LJ, Barr RJ. Histologic atypia in clinically benign nevi. J Am Acad Dermatol 1990;22:275-82.
28. Piepkorn MW. A perspective on the dysplastic nevus controversy. Pathology 1994;2:259-79.
29. Urso C. Atypical histologic features in melanocytic nevi. Am J Dermatopathol 2000;22:391-6.
30. Piepkorn M. A hypothesis incorporating the histologic characteristics of dysplastic nevi into the normal biological development of melanocytic nevi. Arch Dermatol 1990;126:514-8.
31. Marras S, Faa G, Dettori T, Congiu L, Vanni R. Chromosomal changes in dysplastic nevi. Cancer Genet Cytogenet 1999;113:177-9.
32. Sanford KK, Parshad R, Price FM, Tarone RE, Thompson J, Guerry D. Radiation-induced chromatid breaks and DNA repairs in blood lymphocytes of patients with dysplastic nevi and/or cutaneous melanoma. J Invest Dermatol 1997;109:546-9.
33. Hussein MR, Wood GS. Molecular aspects of melanocytic dysplastic nevi. J Mol Diagn 2002;4:71-80.
34. Kopf AW, Goldman RL, Rivers JK, Levenstein M, Rigel DS, Friedman RJ, et al. Skin types in dysplastic nevus syndrome. J Dermatol Surg Oncol 1988;14:827-31.
35. Landi MT, Bacarelli A, Tarone RE, Pesatori A, Tucker MA, Hedayati M, et al. DNA repair, dysplastic nevi, and sunlight sensitivity in the development of cutaneous malignant melanoma. J Natl Cancer Inst 2002;16:94-101.
36. Abadir MC, Marghoob AA, Slade J, Salopek TG, Yadav S, Kopf AW. Case-control study of melanocytic nevi on the buttocks in the atypical mole syndrome: role of solar radiation in the pathogenesis of atypical moles. J Am Acad Dermatol 1995;33:31-6.
37. Devereux DF. Diagnosis and management of dysplastic nevus syndrome and early melanoma. Oncology 1990;4:73-81.
38. Stoltz W, Landthaler M. Classification, diagnosis and differential diagnosis of malignant melanoma. Chirurg 1994;65:145-52.
39. Soyer HP, Kenet RO, Wolf IH, Kenet BJ, Cerroni I. Clinicopathological correlation of pigmented skin lesions using dermascopy. Eur J Dermatol 2000;10:22-8.
40. Elder DE. Dysplastic nevi; their significance and management. Dermatol Clin 1988;6:257-69.
41. Cohen LM, Hodge SJ, Owen LG. Atypical melanocytic nevi; clinical and histologic predictors of residual tumor at reexcision. J Am Acad Dermatol 1992;5:701-6.